New hire brings over 20 years of commercial life sciences sales experience to Cyntellect
SAN DIEGO, Nov. 21 /PRNewswire/ -- Cyntellect, a privately-held life sciences company leading the development and commercialization of live cell analysis and manipulation systems, announced today that it has appointed Andre Lubarsky as the Company's Director of Sales - North America. Andre will be responsible for the sales of Cyntellect's cell purification and cell health products in the life sciences research market. He joins Cyntellect with an extensive sales and sales management background at leading life sciences companies including BD Biosciences, Applied Imaging and Leica Inc.
"Andre's extensive sales and sales management experience in the life sciences research market, particularly in the cellular bioassay and analysis markets, will accelerate the commercialization of Cyntellect's products for applications in biopharmaceutical cell line development, cell line development for drug discovery and research including key applications utilizing stem cells and primary cells," said Fred Koller, Ph.D., Cyntellect's President and Chief Executive Officer. "We are very pleased to have someone of Andre's experience and customer-focused nature join the Cyntellect commercial team."
Andre comes to Cyntellect from BD Biosciences Bioimaging Systems where he filled the role of Director of Sales - North America. Prior to that, he was National Imaging Sales Manager at McBain Instruments in Chatsworth, CA. Andre joined McBain Instruments from a role as Senior Sales Manager at Applied Imaging in Santa Clara, CA. Andre's prior experience included other executive sales management positions with Leica Inc., Bio-Rad Laboratories and Cambridge Instruments. Andre graduated in Biological Sciences from the University of California - San Diego.
Cyntellect, Inc. is a life sciences company committed to revolutionizing the use of living cells in life science research and cellular therapy. The Company combines expertise in high-speed cell imaging and laser-based manipulation to develop products that enable novel cell imaging, purification, and transfection capabilities to enhance the productivity of laboratory research, recombinant protein production, high-content cellular assays, functional genomics and proteomics, and cell purification, including processing of cells for therapeutic transplantation. For additional information please visit the Company's web site at www.cyntellect.com.
SOURCE Cyntellect, Inc.